Clinical Trial Update: A First-in-Human Phase 1 Safety and Biodistribution of [177Lu]Lu-ABY-271 in Subjects With HER2-positive Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

First-in-human Phase 1 trial evaluating the safety and biodistribution of the radiopharmaceutical [177Lu]Lu-ABY-271 in HER2-positive metastatic breast cancer; a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• [177Lu]Lu-ABY-271 (Lutetium-177 ABY-271)

Snippet

Sponsor: Affibody | Conditions: Metastatic Breast Cancer, HER2 + Breast Cancer | Phase 1 | Status: RECRUITING